Opinion

Memorial Sloan Kettering Radiation Oncology – Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer

Photo from Memorial Sloan Kettering Radiation Oncology/X

Apr 8, 2024, 12:28

Memorial Sloan Kettering Radiation Oncology – Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer

Memorial Sloan Kettering Radiation Oncology shared on X:

“New in International Journal of Radiation Oncology, Biology, Physics: Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer treated with IMRT was similar to, but not improved over, conventional, 3D-conformal radiation. Breast cancer serial MRIs may detect early capsular contracture.”

Proceed to the article.
Source: Memorial Sloan Kettering Radiation Oncology/X

Breast Cancer cancer IJROBP - The Red Journal IMRT International Journal of Radiation Oncology Memorial Sloan Kettering Radiation Oncology OncoDaily Oncology radiation oncology radiation therapy

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers